Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 4/2011

01-04-2011 | Case Based Review

Familial hypophosphatemia: an unusual presentation with low back ache, heel pain, and a limp in a young man, and literature review

Authors: Sharon Arthur, Arvind Chopra

Published in: Clinical Rheumatology | Issue 4/2011

Login to get access

Abstract

A case of young man with low back ache and heel pains who was examined in a rheumatology outpatient and diagnosed as familial hypophosphatemia (FH), probably X-linked (XL), is presented. FH is most commonly transmitted as XL. The role of PHEX gene and fibroblast growth factor 23 is also described.
Literature
1.
Xia W, Meng X, Jiang Y, Li M, Xing X, Pang L et al (2007) Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets. Calcif Tissue Int 81(6):415–420PubMedCrossRef
2.
Econs MJ, Francis F (1997) Positional cloning of the PHEX gene: new insights into the pathophysiology of X-linked hypophosphatemic rickets. Am J Physiol 273:F489–F498PubMed
3.
Prié D, Friedlander G (2010) Genetic disorders of renal phosphate transport. N Engl J Med 362(25):2399–2409PubMedCrossRef
4.
Saito T, Nishii Y, Yasuda T, Ito N, Suzuki H, Igarashi T et al (2009) Familial hypophosphatemic rickets caused by a large deletion in PHEX gene. Eur J Endocrinol 161(4):647–651PubMedCrossRef
5.
Qiu G, Liu C, Zhou J, Liu P, Wang J, Jiang H et al (2010) Prenatal diagnosis for a novel splice mutation of PHEX gene in a large Han Chinese family affected with X-linked hypophosphatemic rickets. Genet Test Mol Biomarkers 14(3):385–391PubMedCrossRef
6.
Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM (2009) Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcif Tissue Int 85(3):235–246PubMedCrossRef
7.
Bastepe M, Jüppner H (2008) Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocr Metab Disord 9(2):171–180PubMedCrossRef
8.
White KE, Larsson TE, Econs MJ (2006) The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev 27(3):221–241PubMedCrossRef
9.
Grondel IM, van der Deure J, Zanen AL, Dogger M, van den Heuvel LP (2009) A familial disorder with low bone density and renal phosphate wasting. Eur J Intern Med 20(5):503–508PubMedCrossRef
10.
Shields ED, Scriver CR, Reade T, Fujiwara TM, Morgan K, Ciampi A, Schwartz S (1990) X-linked hypophosphatemia: the mutant gene is expressed in teeth as well as in kidney. Am J Hum Genet 46:434–442PubMed
11.
Murthy AS (2009) X-linked hypophosphatemic rickets and craniosynostosis. J Craniofac Surg 20(2):439–442PubMedCrossRef
12.
Cho HY, Lee BH, Kang JH, Ha IS, Cheong HI, Choi Y (2005) A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res 58(2):329–333PubMedCrossRef
13.
Greene WB, Kahler SG (1985) Hypophosphatemic rickets: still misdiagnosed and inadequately treated. South Med J 78(10):1179–1184PubMed
14.
Pereira CM, de Andrade CR, Vargas PA, Coletta RD, de Almeida OP, Lopes MA (2004) Dental alterations associated with X-linked hypophosphatemic rickets. J Endod 30:241–245PubMedCrossRef
15.
Moser CR, Fessel WJ (1974) Rheumatic manifestations of hypophosphatemia. Arch Intern Med 134(4):674–678PubMedCrossRef
16.
Polisson RP, Martinez S, Khoury M, Harrell RM, Lyles KW, Friedman N, Harrelson JM, Reisner E, Drezner MK (1985) Calcification of entheses associated with X-linked hypophosphatemic osteomalacia. N Engl J Med 313(1):1–6PubMedCrossRef
17.
Adams JE, Davies M (1986) Intra-spinal new bone formation and spinal cord compression in familial hypophosphataemic vitamin D resistant osteomalacia. Q J Med 61(236):1117–1129PubMed
18.
Bussière JL, Ristori JM, Miravet L, Piat C, Soubrier M, Bardin T (1993) [Vitamin-resistant hypophosphatemic rickets and spinal cord compression. Apropos of 2 cases]. Rev Rhum Ed Fr 60(1):64–68PubMed
19.
Econs MJ, Samsa GP, Monger M, Drezner MK, Feussner JR (1994) X-Linked hypophosphatemic rickets: a disease often unknown to affected patients. Bone Miner 24(1):17–24PubMedCrossRef
20.
Alon US, Monzavi R, Lilien M, Rasoulpour M, Geffner ME, Yadin O (2003) Hypertension in hypophosphatemic rickets–role of secondary hyperparathyroidism. Pediatr Nephrol 18(2):155–158PubMed
21.
Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP (1989) X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine (Baltimore) 68(6):336–352
22.
Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 95(4):1846–1850PubMedCrossRef
23.
Seikaly MG, Brown R, Baum M (1997) The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Pediatrics 100:879–884PubMedCrossRef
24.
Carpenter TO, Mitnick MA, Ellison A, Smith C, Insogna KL (1994) Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia. J Clin Endocrinol Metab 78(6):1378–1383PubMedCrossRef
25.
McHenry CR, Mostafavi K, Murphy TA (2006) Tertiary hyperparathyroidism attributable to long-term oral phosphate therapy. Endocr Pract 12(3):294–298PubMed
26.
Nehgme R, Fahey JT, Smith C, Carpenter T (1997) Cardiovascular abnormalities in patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 82:2450–2454PubMedCrossRef
27.
Reusz GS (1995) Guide-lines to the treatment of patients with X-linked hypophosphatemic rickets. Acta Biomed Ateneo Parmense 66(3–4):147–151PubMed
28.
Raeder H, Shaw N, Netelenbos C, Bjerknes R (2008) A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet. Eur J Endocrinol 159(Suppl 1):S101–S105PubMedCrossRef
Metadata
Title
Familial hypophosphatemia: an unusual presentation with low back ache, heel pain, and a limp in a young man, and literature review
Authors
Sharon Arthur
Arvind Chopra
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1607-z

Other articles of this Issue 4/2011

Clinical Rheumatology 4/2011 Go to the issue

Brief Report

Early rheumatoid arthritis—do we really know what it means? Consistency and distribution of MRI findings according to different definitions for early rheumatoid arthritis

Original Article

Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease

Case Based Review

Sarcoid-like granulomatosis in patients treated with anti-TNFα factors. A case report and review of the literature

Letter to the Editor

Reparative radiological changes of a large joint after adalimumab for rheumatoid arthritis

Original Article

Thrombin generation in ankylosing spondylitis

Case Based Review

Cutaneous manifestations of Churg–Strauss syndrome: report of two cases and review of the literature
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits